Showing results (11-20 of 895) with videos related to
Sort By:
Pageof 90
Thrombosis Research|September 28, 1999
Replacement of coagulation factors in liver or multiple organ dysfunctionM Spannagl, W SchrammHamostaseologie|September 6, 2006
[Safety of plasma-derived factor concentrates: an example of pharmacovigilance with fibrinogen and factor XIII-concentrate]M Spannagl, Ch Joch, B HeindlArteriosclerosis, Thrombosis, and Vascular Biology|October 13, 2001
Phosphatidylethanolamine participates in the stimulation of the contact system of coagulation by very-low-density lipoproteinsS Klein, M Spannagl, B EngelmannDer Anaesthesist|June 4, 2005
[High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion]B Heindl, C Delorenzo, M SpannaglDer Anaesthesist|April 1, 2003
[Point-of-care testing of hemostatic alterations in anaesthesia and intensive care]A Calatzis, M Heesen, M SpannaglAnnals of Hematology|August 1, 1992
Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosusT Sitter, M Spannagl, H SchifflFolia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
A new AT III-heparin-complex preparation: in vitro and in vivo characterisationM Spannagl, R Keller, W SchrammDer Anaesthesist|October 14, 2009
[Perioperative management of patients with coronary stents in non-cardiac surgery]C Jámbor, M Spannagl, B ZwisslerHamostaseologie|September 19, 2009
[Morbidity and mortality of patients with haemophilia in Germany 2007/2008]H Krebs, M Spannagl, W Schramm, et al.The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|August 16, 2000
Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?M Spannagl, L A Heinemann, W SchrammPageof 90